S&P Futures
4,577.75 -23.00 (-0.50%) Dow Futures
36,178.00 -125.00 (-0.34%) Nasdaq Futures
15,919.25 -104.50 (-0.65%) Russell 2000 Futures
1,870.20 +4.50 (+0.24%) Crude Oil
73.45 -0.62 (-0.84%) Gold
2,079.60 -10.10 (-0.48%)
Protagonist Therapeutics, Inc. (PTGX)
Pre-Market:
Chart Events
Performance Outlook
| Previous Close | 18.21 |
| Open | 18.12 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 800 |
| Day's Range | 17.81 - 18.74 |
| 52 Week Range | 7.45 - 30.10 |
| Volume | |
| Avg. Volume | 651,396 |
| Market Cap | 1.071B |
| Beta (5Y Monthly) | 1.88 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.61 |
| Earnings Date | Nov 02, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 39.40 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for PTGX
Related Research
- Protagonist Therapeutics, Inc.Daily – Vickers Top Buyers & Sellers for 11/22/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat12 days agoArgus Research
ACCESSWIREProtagonist Announces Two New Phase 3 ICONIC Studies in Psoriasis Evaluating JNJ-2113 in Head-to-Head Comparisons with Deucravacitinib
The ICONIC program now includes four Phase 3 studies evaluating JNJ-2113; Co-primary endpoints for all four studies are PASI-90 and/or IGA 0 or 1Protagonist eligible to receive $115 million milestone upon achieving the co-primary endpoints in any ...
- ACCESSWIRE
Protagonist Therapeutics Reports Granting of Inducement Awards
NEWARK, CA / ACCESSWIRE / November 16, 2023 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on November 15, 2023, it issued inducement awards to two recently hired employees in accordance with the terms of their employment offer ...
Motley FoolLooking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
Maybe you could find out which stocks a well-known company that has been successful for a long time really likes -- a company such as Johnson & Johnson (NYSE: JNJ). Here are the three stocks that J&J is betting the most on. As of Sept. 30, 2023, Johnson & Johnson's biggest investment was in Legend Biotech (NASDAQ: LEGN).
